340B Drug Cuts Threaten FQHC Survival

The One Big Beautiful Bill's Medicaid cuts put a $81 billion drug discount program at risk - and the clinics serving 32 million underserved Americans will pay the price.

The drug program keeping free clinics alive is on the chopping block.

And most people outside of healthcare have never heard of it.

The 340B Drug Pricing Program requires pharmaceutical manufacturers to sell outpatient drugs to eligible safety-net providers at dramatically reduced prices - sometimes 25 to 50 percent below market. For Federally Qualified Health Centers, rural health clinics, and disproportionate share hospitals, 340B is not a perk. It is often the financial engine that keeps the doors open.

Now, a combination of forces is threatening to shutter that engine. The One Big Beautiful Bill Act, signed in July 2025, cuts an estimated $911 billion from Medicaid over the next decade. Separate regulatory changes are moving 340B program oversight from HRSA to CMS. And proposed contract pharmacy restrictions continue moving through the courts. Each threat, taken alone, is survivable. Together, they constitute an existential challenge for the safety-net providers that depend on 340B m…